[1]常文丽,李晓华,邵秋香,等.中药口服液联合中药直肠滴入对溃疡性直肠炎临床疗效和炎症因子及凝血指标的影响[J].西部中医药,2023,36(08):119-122.[doi:10.12174/j.issn.2096-9600.2023.08.29]
 CHANG Wenli,LI Xiaohua,SHAO Qiuxiang,et al.Clinical Effects of Oral Liquid of Chinese Medicine and Rectal Dripping of Chinese Medicine in the Treatment of Ulcerative Rectitis and Its Impacts on Inflammatory Factors and Coagulation Indicators[J].Western Journal of Traditional Chinese Medicine,2023,36(08):119-122.[doi:10.12174/j.issn.2096-9600.2023.08.29]
点击复制

中药口服液联合中药直肠滴入对溃疡性直肠炎临床疗效和炎症因子及凝血指标的影响
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年08期
页码:
119-122
栏目:
出版日期:
2023-08-15

文章信息/Info

Title:
Clinical Effects of Oral Liquid of Chinese Medicine and Rectal Dripping of Chinese Medicine in the Treatment of Ulcerative Rectitis and Its Impacts on Inflammatory Factors and Coagulation Indicators
作者:
常文丽, 李晓华, 邵秋香, 崔书德, 黄晓明, 巩苓苓, 邢志勇, 肖彬
河北省沧州中西医结合医院,河北 沧州 061001
Author(s):
CHANG Wenli, LI Xiaohua, SHAO Qiuxiang, CUI Shude, HUANG Xiaoming, GONG Lingling, XING Zhiyong, XIAO Bin
Cangzhou Hospital of Integrated TCM-WM, Cangzhou 061001, China
关键词:
直肠炎溃疡性中药口服液中药直肠滴入护理效果
Keywords:
rectitis ulcerativeoral liquid of Chinese medicinerectal dripping of Chinese medicinenursing effect
分类号:
R574.63
DOI:
10.12174/j.issn.2096-9600.2023.08.29
文献标志码:
B
摘要:
目的观察中药口服液联合中药直肠滴入对溃疡性直肠炎的护理效果。 方法将76例溃疡性直肠炎患者分为对照组和观察组,每组38例。给予对照组肠炎宁口服液联合护理干预,同时给予观察组中药直肠滴入护理。共干预4周。观察两组临床疗效、炎症因子水平、凝血指标、不良反应及护理满意度。 结果观察组总有效率[92.11%(35/38)]明显高于对照组[73.68%(28/38)](P<0.05)。白细胞介素8、白细胞介素27、白细胞介素10及部分凝血活酶时间、凝血酶原时间、D-二聚体水平干预前两组比较,差异无统计学意义(P>0.05),干预后两组均明显改善,且观察组改善较对照组明显(P<0.05)。观察组不良反应发生率[5.26%(2/38)]明显低于对照组[21.05%(8/38)](P<0.05)。 结论中药口服液联合中药直肠滴入可有效抑制溃疡性直肠炎患者的炎症反应,改善患者凝血状态,减少患者不良反应发生率,提高护理满意度。
Abstract:
ObjectiveTo observe nursing effects of oral liquid of Chinese medicine and rectal dripping of Chinese medicine on ulcerative rectitis. MethodsAll 76 patients were allocated to the control group and the observation group, with 38 cases in each group, The control group accepted Changyanning oral liquid and nursing intervention, and the observation group rectal dripping of Chinese medicine. All intervention for four weeks. To observe clincal effects, inflammatory factors, coagulation indexes, adverse reaction and nursing satisfaction in the two groups. ResultsTotal effective rate of the observation group was [92.11%(35/38)], evidently higher than [73.68%(28/38)] of the control group (P<0.05). The difference had no statistical meaning in the levels of IL-8, IL-27, IL-10, partial thromboplastin time, prothrombin time and D-dimer between both groups before the intervention (P>0.05), after the intervention, both groups improved apparently, and the improvements of the observation group were more noticeable than these of the control group (P<0.05). The incidence of adverse reaction of the observation group was [5.26%(2/38)], obviously lower than [21.05%(8/38)] of the control group (P>0.05). ConclusionOral liquid of Chinese medicine and rectal dripping of Chinese medicine could effectively inhibit inflammatory reaction in patients with ulcerative rectitis, improve coagulation state and lower the incidence of adverse reaction, as well as lift nursing satisfaction degree.

相似文献/References:

[1]冉玉.消溃愈疡汤联合艾迪莎治疗溃疡性结肠炎50例[J].西部中医药,2013,26(03):101.
 RAN Yu.XiaoKui YuYangTang and Etiasa in Treating 50 Cases of Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2013,26(08):101.
[2]景姗,王新月,杨雪,等.溃疡性结肠炎大鼠肺、肠组织中TGF-β1、SP-A表达的改变及中药的干预作用*[J].西部中医药,2014,27(03):10.
 JING Shan,WANG Xinyue,YANG Xue,et al.The Expressions of TGF-β1 and SP-A in the Lung and the Intestines of Rats with Ulcerative Colitis and TCM Intervention on the Changes[J].Western Journal of Traditional Chinese Medicine,2014,27(08):10.
[3]武颜荣,阚存玲.固本益肠片联合美沙拉嗪片治疗中重度溃疡性结肠炎19例*[J].西部中医药,2013,26(01):79.
 WU Yanrong,KAN Cunling.Clinical Observation on GuBen Y iChang Tablets and Mesalazine Tablets in Treating Moderate and Severe Ulcerative Colitis:A Report of 19 Cases[J].Western Journal of Traditional Chinese Medicine,2013,26(08):79.
[4]于礼建,吴迪,梁昆,等.加味缪氏止泻方治疗急性放射性直肠炎33例[J].西部中医药,2015,28(06):91.[doi:2015/6/16 0:00:00]
[5]张艳.初发与复发溃疡性结肠炎院外治疗依从性的调查与分析[J].西部中医药,2017,30(02):58.
 ZHANG Yan.Investigation and Analysis of Extramural Hospital Treatment Compliance of Incipient and Relapse Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2017,30(08):58.
[6]丁永福.健脾清肠汤治疗脾虚湿热型溃疡性结肠炎40例[J].西部中医药,2018,31(02):88.
 DING Yongfu.JianPi QingChang Decoction in Treating 40 Cases of Ulcerative Colitis of Spleen-deficiency Damp-heat Pattern[J].Western Journal of Traditional Chinese Medicine,2018,31(08):88.
[7]何永成,马国杰.中医分期治疗溃疡性结肠炎43例[J].西部中医药,2018,31(08):81.
 HE Yongcheng,MA Guojie.TCM Phased Therapy in Treating 43 Cases of Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2018,31(08):81.
[8]杨薇薇.SASP加中药保留灌肠治疗溃疡性结肠炎64例[J].西部中医药,2019,32(01):102.
 YANG Weiwei.Treating 64 Cases of Ulcerative Colitis by SASP and Herbal Retention Enema[J].Western Journal of Traditional Chinese Medicine,2019,32(08):102.
[9]陈步强,常忠生,指导:陆金根.陆金根教授治疗轻中度溃疡性结肠炎学术思想探析[J].西部中医药,2020,33(02):47.[doi:10.12174/j.issn.1004-6852.2020.02.13]
 CHEN Buqiang,CHANG ZhongshengDirector: LU Jingen.Professor Lu Jingen′s Academic Thinking of Treating Mild - to - moderate Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2020,33(08):47.[doi:10.12174/j.issn.1004-6852.2020.02.13]
[10]沈照峰,朱磊,刘亚军,等.基于德尔菲法的溃疡性结肠炎患者相关危险因素调查分析[J].西部中医药,2020,33(04):82.[doi:10.12174/j.issn.1004-6852.2020.04.25]
 SHEN Zhaofeng,ZHU Lei,LIU Yajun,et al.An Investigation into the Related Risk Factors of UC Patients Based on Delphi Method[J].Western Journal of Traditional Chinese Medicine,2020,33(08):82.[doi:10.12174/j.issn.1004-6852.2020.04.25]

备注/Memo

备注/Memo:
常文丽(1978—),女,主管护师。研究方向:肛肠科疾病的护理。河北省中医药管理局科研计划项目(2021320)。
更新日期/Last Update: 2023-08-15